• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Neurol Sci . Early Neurological Manifestations of Hospitalized COVID-19 Patients

tetano

Editor, Senior Moderator
Neurol Sci


. 2020 Jul 2.
doi: 10.1007/s10072-020-04525-z. Online ahead of print.
Early Neurological Manifestations of Hospitalized COVID-19 Patients

Veria Vacchiano[SUP] 1 [/SUP], P Riguzzi[SUP] 2 [/SUP], L Volpi[SUP] 2 [/SUP], M Tappat?[SUP] 2 [/SUP], P Avoni[SUP] 2 3 [/SUP], G Rizzo[SUP] 2 3 [/SUP], L Guerra[SUP] 4 [/SUP], S Zaccaroni[SUP] 4 [/SUP], P Cortelli[SUP] 2 3 [/SUP], R Michelucci[SUP] 2 [/SUP], R Liguori[SUP] 2 3 [/SUP]


AffiliationsExpand

Abstract

Introduction: Neurological manifestations can occur during coronavirus disease 19 (COVID-19). Several pathogenic mechanisms have been hypothesized, without conclusive results. In this study, we evaluated the most frequent neurological symptoms in a cohort of hospitalized COVID-19 patients, and also investigated the possible relationship between plasmatic inflammatory indices and olfactory disorders (ODs) and between muscle pain and creatine kinase (CK).
Methods: We consecutively enrolled hospitalized COVID-19 patients. A structured questionnaire concerning typical and neurological symptoms, focusing on headache, dizziness, ODs, taste disorders (TDs), and muscle pain, was administrated by telephone interviews.
Results: Common neurological symptoms were reported in the early phase of the disease, with a median onset ranging from 1 to 3 days. Headache showed tension-type features and was more frequently associated with a history of headache. Patients with ODs less frequently needed oxygen therapy. Inflammatory indices did not significantly differ between patients with and without ODs. Muscle pain did not show any association with CK level but was more frequently associated with arthralgia and headache.
Conclusion: In our cohort, ODs were an early symptom of COVID-19, more frequently reported by patients with milder forms of disease. Headache in association with arthralgia and muscle pain seems to reflect the common symptoms of the flu-like syndrome, and not COVID-19 infection-specific.

Keywords: COVID-19; Headache; Muscle pain; Neurological manifestations; Test and smell disorders.
 
Back
Top Bottom